NOVO NORDISK A/S

NYSE: NVO (Novo Nordisk A/S)

最近更新时间: 昨天, 12:12AM

45.76

0.89 (1.98%)

  • 1天 1.98%
  • 5天 13.58%
  • 1月 21.67%
  • 6月 -0.39%
  • 今年至今天 -12.66%
  • 1年 -29.44%
  • 5年 19.98%
前收盘价格 44.87
收盘价格 46.31
成交量 30,875,528
平均成交量 (3个月) 20,492,783
市值 202,847,256,576
市盈率 (P/E TTM) 10.64
预期市盈率 (P/E Forward) 13.02
价格/销量 (P/S) 4.03
股市价格/股市净资产 (P/B) 6.40
52周波幅
35.12 (-23%) — 81.44 (77%)
利润日期 6 May 2026
股息率 (DY TTM) 3.50%
营业毛利率 34.51%
营业利益率 (TTM) 49.68%
稀释每股收益 (EPS TTM) 3.67
季度收入增长率 (YOY) 19.50%
季度盈利增长率 (YOY) 14.30%
总债务/股东权益 (D/E MRQ) 85.70%
流动比率 (MRQ) 0.740
营业现金流 (OCF TTM) 131.24 B
杠杆自由现金流 (LFCF TTM) 77.73 B
资产报酬率 (ROA TTM) 23.29%
股东权益报酬率 (ROE TTM) 88.12%

市场趋势

短期 中期
行业 Drug Manufacturers - General (US) 看涨 混合的
Drug Manufacturers - General (全球的) 看涨 混合的
股票 Novo Nordisk A/S 看涨 看跌

AIStockmoo 评分

0.4
分析师共识 -1.5
内部交易活动 NA
价格波动 1.0
技术平均移动指标 0.0
技术振荡指标 2.0
平均 0.38

相关股票

股票 市值 DY P/E（TTM） P/B
NVO 203 B 3.50% 10.64 6.40
NVS 283 B 3.20% 21.26 7.26
LLY 882 B 0.63% 35.09 27.67
JNJ 536 B 2.31% 25.78 6.66
ABBV 363 B 3.18% 100.68 50.46
MRK 277 B 3.86% 31.63 6.11

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
部门 Healthcare
行业 Drug Manufacturers - General
投资方式 Large Core
内部持股比例 0.01%
机构持股比例 9.85%

所有权

姓名 日期 持有股份
Everett Harris & Co /Ca/ 31 Dec 2025 6,407,366
52周波幅
35.12 (-23%) — 81.44 (77%)
中 41.00 (-10.40%)
总计 1 保留
公司 日期 目标价格 调整类型 价格@调整类型
Goldman Sachs 02 Mar 2026 41.00 (-10.40%) 保留 37.76

该时间范围内无数据。

  • 3M
日期 类型 细节
06 May 2026 CNBC Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
04 May 2026 CNBC Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance
02 May 2026 CNBC Weight loss and hair loss: The growing hair treatment market from GLP-1s
30 Apr 2026 CNBC Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
30 Apr 2026 CNBC FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
21 Apr 2026 CNBC Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access
09 Apr 2026 CNBC As millions lose weight on GLP-1s, they're starting to turn to retailers to refresh their wardrobes
08 Apr 2026 CNBC Trump administration sets up to 100% tariffs on some imported drugs, with many companies exempt
07 Apr 2026 CNBC Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
03 Apr 2026 CNBC Trump tariff fallout: Some industries grapple with lingering effects one year later
31 Mar 2026 CNBC Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
23 Mar 2026 CNBC GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
19 Mar 2026 CNBC FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
05 Mar 2026 CNBC Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
24 Feb 2026 CNBC Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
11 Feb 2026 CNBC Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs
11 Feb 2026 CNBC Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
09 Feb 2026 CNBC Super Bowl 60 recap: Rewatch all the top commercials from advertising's biggest night
09 Feb 2026 CNBC FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims
09 Feb 2026 CNBC Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%
显示更多
股息率 (DY TTM) 3.50%
5年平均股息收益率 2.17%
股息支付比率 47.09%
除息日 公告日期 支付日期 详情
31 Mar 2025 05 Feb 2025 08 Apr 2025 1.099206 现金
16 Aug 2024 06 Aug 2024 26 Aug 2024 0.5126402 现金
22 Mar 2024 31 Jan 2024 02 Apr 2024 0.92985 现金
18 Aug 2023 10 Aug 2023 29 Aug 2023 0.8835613 现金
24 Mar 2023 02 Feb 2023 04 Apr 2023 1.1887415 现金
12 Aug 2022 04 Aug 2022 23 Aug 2022 0.5835507 现金
25 Mar 2022 02 Mar 2022 05 Apr 2022 1.022423 现金
16 Aug 2021 - 25 Aug 2021 0.5502889 现金
26 Mar 2021 - 07 Apr 2021 0.922122 现金
14 Aug 2020 06 Aug 2020 25 Aug 2020 0.5177774 现金
27 Mar 2020 06 Feb 2020 07 Apr 2020 0.7826048 现金
16 Aug 2019 10 Aug 2019 27 Aug 2019 0.449438 现金
22 Mar 2019 05 Feb 2019 02 Apr 2019 0.777006 现金
17 Aug 2018 09 Aug 2018 28 Aug 2018 0.462327 现金
23 Mar 2018 24 Mar 2018 03 Apr 2018 0.805982 现金
17 Aug 2017 - 29 Aug 2017 0.33589 现金
23 Mar 2017 - 04 Apr 2017 0.479369 现金
11 Aug 2016 - 23 Aug 2016 0.331026 现金
18 Mar 2016 - 30 Mar 2016 0.69943 现金
19 Mar 2015 - 31 Mar 2015 0.532885 现金
21 Mar 2014 - 02 Apr 2014 0.606122 现金
21 Mar 2013 - 02 Apr 2013 2.264307 现金
22 Mar 2012 - 03 Apr 2012 1.831902 现金
24 Mar 2011 - 05 Apr 2011 1.357901 现金
25 Mar 2010 - 07 Apr 2010 0.978615 现金
19 Mar 2009 - 31 Mar 2009 0.781532 现金
13 Mar 2008 - 25 Mar 2008 0.678462 现金
08 Mar 2007 - 20 Mar 2007 0.891779 现金
09 Mar 2006 - 21 Mar 2006 0.691753 现金
10 Mar 2005 - 22 Mar 2005 0.61725 现金
17 Mar 2004 - 29 Mar 2004 0.52096 现金
26 Mar 2003 - 07 Apr 2003 0.37647 现金
13 Mar 2002 - 25 Mar 2002 0.2848 现金
21 Mar 2001 - 02 Apr 2001 0.5681 现金
24 Mar 2000 - 06 Apr 2000 0.4672 现金
25 Mar 1999 - 06 Apr 1999 0.4182 现金
27 Mar 1998 - 08 Apr 1998 0.3051 现金
25 Apr 1997 - 07 May 1997 0.239 现金
01 May 1996 - 14 May 1996 0.1806 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 1.10 1 2.16
2024 1.44 2 1.68
2023 2.07 2 2.00
2022 1.61 2 2.37
2021 1.47 2 2.63
2020 1.30 2 3.72
2019 1.23 2 4.24
2018 1.27 2 5.51
2017 0.815 2 3.04
2016 1.03 2 5.75
2015 0.533 1 1.84
2014 0.606 1 2.86
2013 2.26 1 12.26
2012 1.83 1 11.22
2011 1.36 1 11.78
2010 0.979 1 8.69
2009 0.782 1 12.24
2008 0.678 1 13.20
2007 0.892 1 13.75
2006 0.692 1 16.54
2005 0.617 1 21.94
2004 0.521 1 19.20
2003 0.376 1 18.38
2002 0.285 1 19.71
2001 0.568 1 28.33
2000 0.467 1 26.40
1999 0.418 1 32.36
1998 0.305 1 22.94
1997 0.239 1 16.57
1996 0.181 1 19.32
显示更多

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明：以上内容仅供参考，并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票